HINAL PATEL: Open Payments
NPI 1578153946 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 31 payments from 12 companies in 2025. Trend: 2023 $483 · 2024 $523 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $134 |
| Novo Nordisk Inc | 7 | $118 |
| Lilly USA, LLC | 4 | $76 |
| Exact Sciences Corporation | 4 | $76 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
Products named: Xhance, Cologuard Collection Kit, NEFFY, Wegovy, MOUNJARO, Ozempic, Kerendia, FARXIGA.
Industry payments across NJ — which companies pay providers there.
